Latest Biotech News

Remynd NV reported positive Phase IIa results for its investigational Alzheimer's drug REM-127, demonstrating improvements in cognition and reduced tau protein pathology by targeting calcium...

Sapio Sciences and Ultima Genomics have formed a strategic partnership to seamlessly combine Sapio’s AI-powered lab informatics platform with Ultima’s high-throughput, cost-effective sequencing...

Exact Sciences has launched Cancerguard, a multi-cancer early detection blood test capable of identifying over 50 cancer types with up to 68 percent sensitivity in the deadliest cancers. The test...

Merck has announced the closure of its London R&D lab, citing concerns over the UK’s life sciences policies, following similar moves by AstraZeneca and Eli Lilly. AstraZeneca paused a $271 million...

Researchers employing artificial intelligence have achieved unprecedented success designing novel peptides with potential therapeutic applications, transforming traditional drug discovery...

The FDA released draft guidelines to support pharmaceutical companies in developing non-opioid medications for chronic pain management, promoting broader indications and clinical trial strategies...

Utilizing terabase-scale long-read sequencing, researchers have accessed previously uncultured soil bacterial genomes to uncover hundreds of new microbial species and identify novel bioactive...

Merck has announced the termination of plans for its $1.3 billion London lab and is ceasing discovery research activities in the UK. This decision mirrors growing industry concerns over the UK...

Novo Nordisk has announced significant restructuring measures, including cutting 9,000 jobs (about 11% of its workforce) and instructing all employees to return to the office full-time. These...

Capsida Biotherapeutics has suspended its phase I/II clinical trial of CAP-002, a novel gene therapy targeting STXBP1 encephalopathy, following the death of the first pediatric patient enrolled....

LB Pharmaceuticals successfully completed an initial public offering, raising $285 million in the largest biotech IPO since February 2025. The offering exceeded earlier projections, pricing 19...

Maze Therapeutics reported positive phase 1 data for MZE-782, an oral inhibitor targeting SLC6A19 with potential applications in phenylketonuria (PKU) and chronic kidney disease (CKD). The...

VedaBio acquired a broad portfolio of CRISPR diagnostic intellectual property from Mammoth Biosciences, enhancing its amplification-free point-of-care molecular diagnostic platform. This...

A new data portal by AtlasXomics hosts spatial epigenomics datasets generated via Deterministic Barcoding in Tissue sequencing (DBiT-seq), enabling researchers to explore gene regulation in native...

The US Food and Drug Administration issued draft guidance designed to facilitate development of non-opioid therapies for chronic pain. The recommendations outline clinical trial design...

The prestigious 2025 Lasker Awards honored foundational discoveries in molecular biology and transformative medical research. Dirk Görlich and Steven McKnight received the Basic Medical Research...

Recent research published in Nature reveals that small cell lung cancer (SCLC) cells can form functional synapses with neurons, integrating into neural circuits to promote tumor progression. This...

Merck has made a decisive move to halt its research and discovery operations in the United Kingdom, including abandoning its £1 billion London lab project. The decision stems from frustrations...

Novo Nordisk has announced a significant restructuring plan, involving the cutting of approximately 9,000 jobs, representing an 11% workforce reduction. This strategic pivot aligns with a...

Recent studies have unveiled that small cell lung cancer (SCLC) cells establish functional synaptic connections with neurons, integrating into the nervous system circuitry. These neural synapses...